TrialAntimicrobial agents and chemotherapy2017

Safety, Tolerability, and Pharmacokinetics of MEDI8897, the Respiratory Syncytial Virus Prefusion F-Targeting Monoclonal Antibody with an Extended Half-Life, in Healthy Adults.

M Pamela Griffin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.